000154348 001__ 154348
000154348 005__ 20250417133750.0
000154348 0247_ $$2doi$$a10.1002/ana.25901
000154348 0247_ $$2pmid$$apmid:32935385
000154348 0247_ $$2ISSN$$a0364-5134
000154348 0247_ $$2ISSN$$a1531-8249
000154348 0247_ $$2altmetric$$aaltmetric:90341071
000154348 037__ $$aDZNE-2021-00202
000154348 041__ $$aEnglish
000154348 082__ $$a610
000154348 1001_ $$aTetreault, Aaron M$$b0
000154348 245__ $$aNetwork Localization of Alien Limb in Patients with Corticobasal Syndrome.
000154348 260__ $$aHoboken, NJ$$bWiley-Blackwell$$c2020
000154348 3367_ $$2DRIVER$$aarticle
000154348 3367_ $$2DataCite$$aOutput Types/Journal article
000154348 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744889821_17132
000154348 3367_ $$2BibTeX$$aARTICLE
000154348 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154348 3367_ $$00$$2EndNote$$aJournal Article
000154348 500__ $$aISSN 1531-8249 not unique: **3 hits**.
000154348 520__ $$aPerirolandic atrophy occurs in corticobasal syndrome (CBS) but is not specific versus progressive supranuclear palsy (PSP). There is heterogeneity in the locations of atrophy outside the perirolandic cortex and it remains unknown why atrophy in different locations would cause the same CBS-specific symptoms. In prior work, we used a wiring diagram of the brain called the human connectome to localize lesion-induced disorders to symptom-specific brain networks. Here, we use a similar technique termed 'atrophy network mapping' to localize single-subject atrophy maps to symptom-specific brain networks.Single-subject atrophy maps were generated by comparing cortical thickness in patients with CBS versus controls. Next, we performed seed-based functional connectivity using a large normative connectome to determine brain regions functionally connected to each patient's atrophied locations.Patients with CBS had perirolandic atrophy versus controls at the group level, but locations of atrophy in CBS were heterogeneous outside of the perirolandic cortex at the single-subject level (mean spatial correlation = 0.04). In contrast, atrophy occurred in locations functionally connected to the perirolandic cortex in all patients with CBS (spatial correlation = 0.66). Compared with PSP, patients with CBS had atrophy connected to a network of higher-order sensorimotor regions beyond perirolandic cortex, matching a CBS atrophy network from a recent meta-analysis. Finally, atrophy network mapping identified a symptom-specific network for alien limb, matching a lesion-induced alien limb network and a network associated with agency in healthy subjects.We identified a syndrome-specific network for CBS and symptom-specific network for alien limb using single-subject atrophy maps and the human connectome. ANN NEUROL 2020;88:1118-1131.
000154348 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000154348 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000154348 650_2 $$2MeSH$$aAlien Limb Phenomenon: pathology
000154348 650_2 $$2MeSH$$aAged
000154348 650_2 $$2MeSH$$aAlien Hand Syndrome: pathology
000154348 650_2 $$2MeSH$$aAtrophy: pathology
000154348 650_2 $$2MeSH$$aCase-Control Studies
000154348 650_2 $$2MeSH$$aCerebral Cortex: pathology
000154348 650_2 $$2MeSH$$aConnectome
000154348 650_2 $$2MeSH$$aHumans
000154348 650_2 $$2MeSH$$aMale
000154348 650_2 $$2MeSH$$aMiddle Aged
000154348 650_2 $$2MeSH$$aSupranuclear Palsy, Progressive: pathology
000154348 650_2 $$2MeSH$$aSyndrome
000154348 7001_ $$aPhan, Tony$$b1
000154348 7001_ $$aPetersen, Kalen J$$b2
000154348 7001_ $$0P:(DE-HGF)0$$aClaassen, Daniel O$$b3
000154348 7001_ $$0P:(DE-HGF)0$$aNeth, Byran J$$b4
000154348 7001_ $$0P:(DE-HGF)0$$aGraff-Radford, Jonathan$$b5
000154348 7001_ $$aAlbrecht, Franziska$$b6
000154348 7001_ $$0P:(DE-HGF)0$$aFliessbach, Klaus$$b7
000154348 7001_ $$0P:(DE-2719)2812035$$aSchneider, Anja$$b8$$udzne
000154348 7001_ $$aSynofzik, Matthis$$b9
000154348 7001_ $$aDiehl-Schmid, Janine$$b10
000154348 7001_ $$aOtto, Markus$$b11
000154348 7001_ $$aSchroeter, Matthias L$$b12
000154348 7001_ $$0P:(DE-HGF)0$$aDarby, Richard Ryan$$b13$$eCorresponding author
000154348 7001_ $$aInitiative, 4 Repeat Tau Neuroimaging$$b14$$eCollaboration Author
000154348 773__ $$0PERI:(DE-600)2037912-2$$a10.1002/ana.25901$$gVol. 88, no. 6, p. 1118 - 1131$$n6$$p1118 - 1131$$tAnnals of neurology$$v88$$x1531-8249$$y2020
000154348 8564_ $$uhttps://pub.dzne.de/record/154348/files/DZNE-2021-00202_Restricted.pdf
000154348 8564_ $$uhttps://pub.dzne.de/record/154348/files/DZNE-2021-00202_Restricted.pdf?subformat=pdfa$$xpdfa
000154348 909CO $$ooai:pub.dzne.de:154348$$pVDB
000154348 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812035$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000154348 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000154348 9132_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154348 9141_ $$y2020
000154348 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-02-03$$wger
000154348 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000154348 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-03
000154348 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000154348 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-30$$wger
000154348 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN NEUROL : 2021$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-30
000154348 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bANN NEUROL : 2021$$d2022-11-30
000154348 9201_ $$0I:(DE-2719)1440011$$kAG Schneider Göttingen$$lTranslational Dementia Research Göttingen$$x0
000154348 980__ $$ajournal
000154348 980__ $$aVDB
000154348 980__ $$aI:(DE-2719)1440011
000154348 980__ $$aUNRESTRICTED